| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/08/2002 | WO2002061074A1 Novel protein and dna thereof |
| 08/08/2002 | WO2002061070A2 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 08/08/2002 | WO2002061069A1 Runx3 gene showing anti-tumor activity and use thereof |
| 08/08/2002 | WO2002061061A2 Inhibition of interleukin-1-beta secretion by card proteins |
| 08/08/2002 | WO2002061054A2 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel |
| 08/08/2002 | WO2002061049A2 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 08/08/2002 | WO2002061046A2 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | WO2002061044A2 Synthetic peptide and uses for same |
| 08/08/2002 | WO2002061042A2 Genetic control of organ abscission |
| 08/08/2002 | WO2002061041A2 Solubility reporter gene constructs |
| 08/08/2002 | WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/08/2002 | WO2002061039A2 Thuja plicata dirigent protein promotors |
| 08/08/2002 | WO2002061037A2 Administration of nucleic acid sequence to female animal |
| 08/08/2002 | WO2002060953A2 Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer |
| 08/08/2002 | WO2002060952A1 Serpin variants and uses thereof |
| 08/08/2002 | WO2002060951A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060948A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/08/2002 | WO2002060947A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060946A2 Methods and compositions relating to cardiac-specific nuclear regulatory factors |
| 08/08/2002 | WO2002060945A2 Human ion channel protein and polynucleotides encoding the same |
| 08/08/2002 | WO2002060944A1 Peptides specific to tcr cdr3 of infiltrating t cells derived from patients with psoriasis and uses thereof |
| 08/08/2002 | WO2002060943A1 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060941A2 Fluorescent proteins |
| 08/08/2002 | WO2002060938A2 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof |
| 08/08/2002 | WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 08/08/2002 | WO2002060936A2 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 08/08/2002 | WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | WO2002060934A2 IDENTIFICATION OF THE ANTI-σ28 FACTOR IN HELICOBACTER PYLORI, IN CAMPYLOBACTER JEJUNI AND IN PSEUDOMONAS AERUGINOSA AND APPLICATION THEREOF |
| 08/08/2002 | WO2002060933A2 Thioredoxin derived from h. pylori, which is capable of inhibiting nf-kappa b activation |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060930A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060928A2 Medane genes and proteins |
| 08/08/2002 | WO2002060927A1 Protein kinase signalling |
| 08/08/2002 | WO2002060925A1 Method of producing latent antithrombin iii |
| 08/08/2002 | WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 08/08/2002 | WO2002060923A2 B-superfamily conotoxins |
| 08/08/2002 | WO2002060920A2 Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers |
| 08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | WO2002060918A2 Haplotypes of the tnf gene |
| 08/08/2002 | WO2002060917A2 Method to treat hemophilia |
| 08/08/2002 | WO2002060914A2 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation |
| 08/08/2002 | WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | WO2002060479A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 08/08/2002 | WO2002060477A1 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same |
| 08/08/2002 | WO2002060475A1 Methods for stabilizing lyophilized blood proteins |
| 08/08/2002 | WO2002060467A2 Compositions and methods for improving kidney function |
| 08/08/2002 | WO2002060466A2 Gssp3 polynucleotides and polypeptides and uses thereof |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060317A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 08/08/2002 | WO2002046208A3 Method of producing biospecific molecules by protein trans-splicing |
| 08/08/2002 | WO2002043746A3 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 08/08/2002 | WO2002040516A3 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
| 08/08/2002 | WO2002038597A3 Genomic fragment of streptococcus suis and clinical uses thereof |
| 08/08/2002 | WO2002036736A3 Alpha-tocopherol transfer protein knockout animals |
| 08/08/2002 | WO2002034945A3 Estrogen receptor alpha variants and methods of detection thereof |
| 08/08/2002 | WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 08/08/2002 | WO2002031153A3 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains |
| 08/08/2002 | WO2002030887A3 Protein having thrombolytic activities extracted from natural product |
| 08/08/2002 | WO2002029062A3 Cytokine proteins |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002022780A3 Methods and materials relating to neuropilin-like polypeptides and polynucleotides |
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002020740A3 Proteolysis targeting chimeric pharmaceutical |
| 08/08/2002 | WO2002020572A3 Nucleotide sequences coding for the chrs gene |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002014366A3 Genes involved in immune related responses observed with asthma |
| 08/08/2002 | WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 08/08/2002 | WO2002012293A3 Hypersensitive response elicitor from xanthomonas campestris |
| 08/08/2002 | WO2002006318A3 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 08/08/2002 | WO2002004614A3 Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use |
| 08/08/2002 | WO2002002807A3 Diagnosis of diseases associated with cell signalling |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 08/08/2002 | WO2002000695A3 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001098455A3 Method for preparing a physiologically active il-18 polypeptide |
| 08/08/2002 | WO2001098349A3 Recombinant avidin monomer and its use in biotin binding |
| 08/08/2002 | WO2001096528A3 Human tumor necrosis factor delta and epsilon |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001096380A3 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
| 08/08/2002 | WO2001096379A3 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 08/08/2002 | WO2001095934A3 The use of plant oil-bodies in vaccine delivery systems |
| 08/08/2002 | WO2001092522A3 Human fgf-20 nucleic acids and polypeptides |
| 08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
| 08/08/2002 | WO2001092298A9 MUTEINS OF A CHAIN OF A PROTEIN FROM THE SUPERFAMILY OF GROWTH FACTOR TGF-$g(b) |
| 08/08/2002 | WO2001092295A3 Ligands for cd21 and compositions thereof for modulating immune responses |
| 08/08/2002 | WO2001091814A3 Polyubiquitin based hydrogel and uses thereof |
| 08/08/2002 | WO2001091536A3 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 08/08/2002 | WO2001090383A3 Co-expression of recombinant proteins |
| 08/08/2002 | WO2001090361A3 Modulation of inflammation by protease-treated mcp-3 chemokine |
| 08/08/2002 | WO2001090309A3 Peptides that stimulate mycobacterial growth |
| 08/08/2002 | WO2001088101A3 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001085972A3 Chlamydia antigens and corresponding dna fragments and uses thereof |